SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zvi Yammer who wrote (1004)1/12/1998 4:25:00 PM
From: Steve Harmon  Read Replies (1) of 2742
 
Zvi Y.,

Thanks for the informative posts on CIST's meeting. The flu kept me away. Two things>>>>

1)The share buyback was a good move for the shareholders.(it increased the value of our shares on paper).
2)The thing that is destroying CIST is LOUSY stock support. Compare CIST with their flu vaccine partner Novavax(NOX). Novavax's products are in early clinical trials also.

CIST has $14.5 mil. in cash and cash rec.
NOX has $ 4 mil.

CIST has a market value of $5 mil.
NOX has a market value of $60 mil.

CIST has 3x the cash that NOX has.
NOX has a market value 12x CIST.

NOX is getting tremendous sponsorship(stock support) from their investment bankers Anaconda Funds. Too bad we didn't hire the Anaconda Funds. I think if they were on board CIST would not be trading at 1/3 cash.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext